US8350047B2 - Methods of preparing secondary carbinamine compounds with boronic acids - Google Patents

Methods of preparing secondary carbinamine compounds with boronic acids Download PDF

Info

Publication number
US8350047B2
US8350047B2 US12/593,815 US59381508A US8350047B2 US 8350047 B2 US8350047 B2 US 8350047B2 US 59381508 A US59381508 A US 59381508A US 8350047 B2 US8350047 B2 US 8350047B2
Authority
US
United States
Prior art keywords
alkyl
alkoxy
compounds
formulae
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US12/593,815
Other versions
US20100298572A1 (en
Inventor
Avinash N. Thadani
Bhartesh Dhudshia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US12/593,815 priority Critical patent/US8350047B2/en
Publication of US20100298572A1 publication Critical patent/US20100298572A1/en
Application granted granted Critical
Publication of US8350047B2 publication Critical patent/US8350047B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/60Preparation of compounds containing amino groups bound to a carbon skeleton by condensation or addition reactions, e.g. Mannich reaction, addition of ammonia or amines to alkenes or to alkynes or addition of compounds containing an active hydrogen atom to Schiff's bases, quinone imines, or aziranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/822Rhodium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2419Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member
    • B01J31/2428Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising P as ring member with more than one complexing phosphine-P atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Definitions

  • the present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds from aldehydes and boronic acids in the presence of ammonia.
  • Amines are one of the most common classes of organic molecules. They play important roles in a variety of areas, ranging from the pharmaceutical industry to plastics manufacturing.
  • the present application includes a method of preparing a secondary amine of the formula Ia and/or Ib:
  • R 1 is selected from C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alknyl, C 3-20 cycloalkyl or C 3-20 cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 ;
  • R 2 to R 6 are independently selected from H, C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, the
  • R 1 is as defined for the compounds of formulae Ia and Ib, with a compound of formula III:
  • R 2 -R 6 are as defined for the compounds of formulae Ia and Ib, in the presence of ammonia NH 3 or an ammonia equivalent of the formula NH 4 + X ⁇ , wherein X is an anionic counterion, and optionally isolating the amine of the formula Ia and/or Ib.
  • the present application relates to a method of preparing an amine of the formula IV:
  • R 1 is selected from C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl or C 3-20 cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 ;
  • R 10 is aryl or heteroaryl, both of which are optionally substituted; and R 7 and R 8 are independently selected from H, C 1-20 alkyl, C 2-20 alkynyl, C 3-20 cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted; comprising reacting
  • R 1 is as defined for the compounds of formula IV, with a compound of the formula V:
  • R 10 is as defined for the compound of formula IV, in the presence of ammonia NH 3 or an ammonia equivalent of the formula NH 4 + X ⁇ , wherein X is an anionic counterion, and optionally isolating the amine of the formula IV.
  • the method of preparing the compounds of the formulae Ia, Ib and IV is performed in the presence of a catalyst, such as a transition metal catalyst.
  • a catalyst such as a transition metal catalyst.
  • the catalyst comprises a chiral ligand and its use results in the preparation of enantiomerically enriched compounds of formulae Ia, Ib and IV.
  • C 1-n alkyl as used herein means straight and/or branched chain alkyl groups containing from one to n carbon atoms and includes, depending on the identity of n, methyl, ethyl, propyl, isopropyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, hexadecyl, octadecyl, icosyl and the like and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • C 3-n cycloalkyl as used herein means saturated cyclic or polycyclic alkyl groups containing from three to n carbon atoms and includes, depending on the identity of n, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclododecyl, cyclohexadecyl, cyclooctadecyl, cycloicosyl, adamantyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • C 1-n alkoxy means straight and/or branched chain alkoxy groups containing from one to n carbon atoms and includes, depending on the identity of n, methoxy, ethoxy, propoxy, isopropoxy, t-butoxy, pentoxy, hexoxy, heptoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, hexadecoxy, octadecoxy, icosoxy and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • C 3-n cycloalkoxy as used herein means saturated cyclic or polycyclic alkoxy groups containing from three to n carbon atoms and includes, depending on the identity of n, cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexoxy, cycloheptoxy, cyclooctoxy, cyclononoxy, cyclodecoxy, cycloundecoxy, cyclododecoxy, cyclohexadecoxy, cyclooctadecoxy, cycloicosoxy and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • C 2-n alkenyl as used herein means straight and/or branched chain alkenyl groups containing from two to n carbon atoms and one to six double bonds and includes, depending on the identity of n, vinyl, allyl, 1-butenyl, 2-hexenyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • C 2-n alkynyl as used herein means straight or branched chain alkynyl groups containing from 2 to n carbon atoms and one to six triple bonds and includes, depending on the identity of n, propargyl, 1-butynyl, 2-hexynyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
  • halo-substituted C 1-n alkyl as used herein means straight or branched chain, saturated alkyl radicals containing from one to n carbon atoms in which one or all of the hydrogen atoms have been replaced with a halogen, in particular fluorine, and includes (depending on the identity of “n”) trifluoromethyl, pentafluoroethyl, fluoromethyl and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkyl radical.
  • halo-substituted C 1-n alkoxy as used herein means straight or branched chain, saturated alkoxy radicals containing from one to n carbon atoms in which one or all of the hydrogen atoms have been replaced with a halogen, in particular fluorine, and includes (depending on the identity of “n”) trifluoromethoxy, pentafluoroethoxy, fluoromethoxy and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkoxy radical.
  • aryl as used herein means a monocyclic or polycyclic carbocyclic ring system containing one or two aromatic rings and from 6 to 14 carbon atoms and includes phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl and the like.
  • heteroaryl as used herein means mono- or polycyclic heteroaromatic radicals containing from 5 to 14 atoms, of which 1 to 4 atoms are a heteroatom selected from nitrogen, oxygen and sulfur and includes furanyl, thienyl, pyrrolo, pyridyl, indolo, benzofuranyl and the like.
  • halo as used herein means halogen and includes chloro, fluoro, bromo and iodo.
  • optionally substituted means unsubstituted or substituted. When a group is substituted it may be substituted one or more times, one to five times, one to three times, one to two times or one time.
  • ammonia equivalent refers to a compound that reacts in situ to produce an equivalent of “NH 3 ” or ammonia.
  • enantiomerically enriched means a mixture of enantiomeric compounds that contains an excess of one enantiomer over the other(s).
  • the present application includes combinations of groups and substituents that are permitted and would provide a stable chemical entity according to standard chemical knowledge as would be known to those skilled in the art.
  • the present application relates to a method of preparing a secondary amine of the formula Ia and/or Ib:
  • R 1 is selected from C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alknyl, C 3-20 cycloalkyl or C 3-20 cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 ;
  • R 2 to R 6 are independently selected from H, C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, the
  • R 1 is as defined for the compounds of formula Ia and Ib, with a compound of formula III:
  • R 2 -R 6 are as defined for the compounds of formulae Ia and Ib, in the presence of ammonia NH 3 or an ammonia equivalent of the formula NH 4 + X ⁇ , wherein X is an anionic counterion, and optionally isolating the amine of the formulae Ia and/or Ib.
  • the compounds of formulae Ia, Ib and II include those in which R 1 is selected from C 1-10 alkyl, C 3-8 cycloalkyl, aryl, and heteroaryl, all of which are optionally substituted.
  • R 1 is selected from C 1-10 alkyl, C 3-8 cycloalkyl, aryl, and heteroaryl, all of which are optionally substituted.
  • one or more of the carbons in C 1-10 alkyl or C 3-8 cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 , in which R 7 and R 8 are independently selected from H and C 1-6 alkyl.
  • one or more of the carbons in C 1-18 alkyl or C 3-8 cycloalkyl is optionally replaced with a heteroatom selected from O and S.
  • the optional substituents on R 1 in the compounds of the formulae Ia, Ib and II are independently selected from one or more of OH, halo, CN, NO 2 , C 1-6 alkyl, halo-substituted C 1-6 alkyl, C 1-6 alkoxy, halo-substituted C 1-6 alkoxy, C 2-8 alkenyl, C 2-8 alkenyloxy, aryl, aryloxy, aryl(C 1-4 alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C 1-4 alkoxy), NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the optional substituents on R 1 in the compounds of the formulae Ia, Ib and II are independently selected from one to three of OH, F, Cl, Br, CN, NO 2 , CF 3 , OCF 3 , C 1-4 alkyl, C 1-4 alkoxy, phenyl, benzyl, benzyloxy and C(O)OC 1-4 alkyl.
  • R 2 to R 6 in the compounds of the formulae Ia, Ib and III are independently selected from H, C 1-10 alkyl, C 3-12 cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted.
  • one or more of the carbons in C 1-10 alkyl or C 3-10 cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 , in which R 7 and R 8 are independently selected from H and C 1-6 alkyl.
  • one or more of the carbons in C 1-10 alkyl or C 3-8 cycloalkyl is optionally replaced with a heteroatom selected from O and S.
  • R 2 to R 6 in the compounds of the formulae Ia, Ib and III are independently selected from H and C 1-6 alkyl. In a more particular embodiment of the application, R 2 to R 6 in the compounds of the formulae Ia, Ib and III are independently selected from H and methyl.
  • the optional substituents on R 2 to R 6 in the compounds of the formulae Ia, Ib and III are independently selected from one or more of OH, halo, CN, NO 2 , C 1-6 alkyl, halo-substituted C 1-6 alkyl, C 1-6 alkoxy, halo-substituted C 1-6 alkoxy, C 2-6 alkenyl, C 2-6 alkenyloxy, aryl, aryloxy, aryl(C 1-4 alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C 1-4 alkoxy), NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the method of preparing compounds of the formulae Ia and/or Ib is performed in the presence of ammonia. In yet another embodiment of the application, the method of preparing compounds of the formulae Ia and/or Ib is performed in the presence of an ammonia salt NH 4 + X ⁇ in which X is an anionic counterion. In a further embodiment of the application, X is selected from halo, R 9 COO, R 9 SO 4 and BF 4 , in which R 9 is selected from C 1-10 alkyl, C 3-20 cycloalkyl, aryl and heteroaryl, all of which are optionally substituted. In an embodiment of the application, X is Cl or Br.
  • the optional substituents on R 9 are independently selected from one or more of OH, halo, CN, NO 2 , phenyl, benzyl, C 1-6 alkoxy, halo-substituted C 1-6 alkoxy, C 1-6 alkyl, halo-substituted C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkenyloxy, NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the method of preparing compounds of formulae Ia and/or Ib is performed in a suitable solvent.
  • the solvent is selected from selected from selected from selected from methanol, ethanol, propanol, butanol, toluene, tetrahydrofuran, acetonitrile, benzene, dioxane, methylene chloride, liquid ammonia, ionic liquids and mixtures thereof.
  • the method of preparing compounds of formulae Ia and/or Ib is performed by combining an alcoholic solution of ammonia, or an ammonia equivalent in a suitable solvent, with the compound of formula II.
  • the ammonia or ammonia equivalent is suitably used in molar excess amounts, for example about 5 to about 20 molar equivalents, relative to the amount of the compound of formula II.
  • the compound of formula III may be added to the combined solution of ammonia or ammonia equivalent and compound of formula II.
  • the compound of formula III may be used in molar excess amounts, for example about 1.1 to about 5 molar equivalents, suitably about 1.2 to 2.5 molar equivalents, relative to the amount of the compound of formula II.
  • the method of preparing compounds of formulae Ia and/or Ib is performed at room temperature or above or below room temperature, for example, at a temperature of from ⁇ 40° C. to +100° C., suitably from 0° C. to 50° C., more suitably from 10° C. to 30° C. In an embodiment of the application, the method is performed at room temperature.
  • reaction conditions including for example, temperature, time and reactant ratios, may vary depending on a number of variables, including, but not limited to, the structure of the starting materials (compounds of formulae II and III), the solvent, presence or absence of a catalyst (vide supra) and the reaction pressure.
  • a person skilled in the art would be able to optimize the reaction conditions to obtain the best yields and overall performance of the reaction based on the results presented herein and methods known in the art. Reaction progress may be monitored using known techniques, for example, thin layer chromatography, high performance liquid chromatography and/or NMR spectroscopy, to determine optimum reaction conditions.
  • the compounds of the formulae Ia and/or Ib may optionally be isolated using standard methods known in the art, for example, by acid/base extraction methods. Further purification steps may be performed, for example, chromatography, and if R 2 and R 3 are different, chiral resolution. Chiral resolution of enantiomers may be performed, for example, by forming chiral esters or salts, followed by separation of the diastereomers using crystallization or chromatographic techniques, and liberation of the free amine.
  • the present application relates to a method of preparing an amine of the formula IV:
  • R 1 is selected from C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl, C 3-20 cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C 1-20 alkyl, C 1-20 alkoxy, C 2-20 alkenyl, C 2-20 alkynyl, C 3-20 cycloalkyl or C 3-20 cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 ;
  • R 10 is aryl or heteroaryl, both of which are optionally substituted; and R 7 and R 8 are independently selected from H, C 1-20 alkyl, C 2-20 alkynyl, C 3-20 cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted; comprising reacting
  • R 1 is as defined for the compounds of formula IV, with a compound of the formula V:
  • R 10 is as defined for the compound of formula IV, in the presence of ammonia NH 3 or an ammonia equivalent of the formula NH 4 + X ⁇ , wherein X is an anionic counterion, and optionally isolating the amine of the formula IV.
  • R 1 in the compounds of the formulae II and IV is selected from C 1-10 alkyl, aryl and heteroaryl, all of which are optionally substituted.
  • one or more of the carbons in C 1-10 alkyl is optionally replaced with a heteromoiety selected from O, S, N, NR 7 and NR 7 R 8 , in which R 7 and R 8 are independently selected from H and C 1-6 alkyl.
  • one or more of the carbons in C 1-10 alkyl is optionally replaced with a heteroatom selected from O and S.
  • the optional substituents on R 1 in the compounds of the formulae II and IV are independently selected from one or more of OH, halo, CN, NO 2 , C 1-6 alkyl, halo-substituted alkyl, C 1-6 alkoxy, halo-substituted alkoxy, C 2-6 alkenyl, C 2-6 alkenyloxy, aryl, aryloxy, aryl(C 1-4 alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C 1-4 alkoxy), NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the optional substituents on R 1 in the compounds of the formulae II and V are independently selected from one to three of OH, F, Cl, Br, CN, NO 2 , CF 3 , OCF 3 , C 1-4 alkyl, C 1-4 alkoxy, phenyl, benzyl, benzyloxy and C(O)OC 1-4 alkyl.
  • R 10 in the compounds of the formulae IV and V is selected from phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl, furanyl, thienyl, pyrrolo, pyridyl, indolo and benzofuranyl, all of which are optionally substituted.
  • R 10 in the compounds of the formulae IV and V is optionally substituted phenyl.
  • the optional substituents on R 10 in the compounds of the formulae IV and V are independently selected from one or more of OH, halo, CN, NO 2 , C 1-6 alkyl, halo-substituted alkyl, C 1-6 alkoxy, halo-substituted alkoxy, C 2-6 alkenyl, C 2-6 alkenyloxy, aryl, aryloxy, aryl(C 1-4 alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C 1-4 alkoxy), NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the optional substituents on R 10 in the compounds of the formulae IV and V are independently selected from on to three of OH, F, Cl, Br, CN, NO 2 , CF 3 , OCF 3 , C 1-4 alkyl, C 1-4 alkoxy, phenyl, benzyl, benzyloxy and C(O)OC 1-4 alkyl.
  • the method of preparing compounds of formula IV is performed in the presence of ammonia. In yet another embodiment of the application, the method of preparing compounds of formula IV is performed in the presence of an ammonia salt NH 4 + X ⁇ in which X is an anionic counter ion. In a further embodiment of the application, X is selected from halo, R 9 COO, R 9 SO 4 and BF 4 , in which R 9 is selected from C 1-10 alkyl, C 3-20 cycloalkyl, aryl and heteroaryl, all of which are optionally substituted. In an embodiment of the application, X is Cl or Br.
  • the optional substituents on R 9 are independently selected from one or more of OH, halo, CN, NO 2 , phenyl, benzyl, C 1-6 alkoxy, halo-substituted alkoxy, C 1-6 alkyl, halo-substituted alkyl, C 2-6 alkenyl, C 2-6 alkenyloxy, NH 2 , NH(C 1-6 alkyl), N(C 1-6 alkyl)(C 1-6 alkyl), C(O)C 1-6 alkyl, C(O)OC 1-6 alkyl, SO 2 C 1-6 alkyl, SO 2 NH 2 , SO 2 NHC 1-6 alkyl and SC 1-4 alkyl.
  • the method of preparing compounds of formula IV is performed in a solvent.
  • the solvent is selected from selected from methanol, ethanol, propanol, butanol, toluene, tetrahydrofuran, acetonitrile, benzene, dioxane, methylene chloride, liquid ammonia, ionic liquids and mixtures thereof.
  • the method of preparing compounds of formula IV is performed by combining an alcoholic solution of ammonia, or an ammonia equivalent in a suitable solvent, with the compound of formula II.
  • the ammonia or ammonia equivalent is suitably used in molar excess amounts, for example about 5 to about 20 molar equivalents, relative to the amount of the compound of formula II.
  • the compound of formula III may be added to the combined solution of ammonia or ammonia equivalent and compound of formula II.
  • the compound of formula V may be used in molar excess amounts, for example about 1.1 to about 5 molar equivalents, suitably about 1.2 to 2.5 molar equivalents, relative to the amount of the compound of formula II.
  • the method of preparing compounds of formula IV is performed at a temperature of from about ⁇ 40° C. to about +150° C. More suitably, in an embodiment of the application, the method is performed at a temperature of from about +50° C. to about +120° C. It is an embodiment of the application that the method is performed at a temperature of about 80° C.
  • reaction conditions including for example, temperature, time and reactant ratios, may vary depending on a number of variables, including, but not limited to, the structure of the starting materials (compounds of formulae II and V), the solvent, presence or absence of a catalyst and the reaction pressure.
  • a person skilled in the art would be able to optimize the reaction conditions to obtain the best yields and overall performance of the reaction based on the results presented herein and methods known in the art. Reaction progress may be monitored using known techniques, for example, thin layer chromatography, high performance liquid chromatography and/or NMR spectroscopy, to determine optimum reaction conditions.
  • the compounds of the formula IV may optionally be isolated using standard methods known in the art, for example, by acid/base extraction methods. Further purification steps may be performed, for example, chromatography, and if R 1 and R 10 are different, chiral resolution. Chiral resolution of enantiomers may be performed, for example, by forming chiral esters or salts, followed by separation of the diastereomers using crystallization or chromatographic techniques, and liberation of the free amine.
  • the methods for preparing compounds of formula Ia, Ib and/or IV are performed in the presence of a catalyst, in particular a transition metal catalyst.
  • the catalyst is any of the well-known transition metal catalysts.
  • the metal is selected from rhodium, ruthenium, iridium, copper, platinum, palladium and nickel.
  • the metal is rhodium.
  • the catalyst may be included in the method, for example, by adding it along with the compound of formula III or V, either by a separate addition or in a combined solution with the compound of formula III or V.
  • a catalyst when a catalyst is used, it is added in amounts of about 1 mol % to about 20 mol %, suitably about 5 mol % to about 10 mol %, based on the amount of the aldehyde.
  • the metal catalyst possesses at least one chiral or achiral ligand.
  • the ligand is a phosphine, diphosphine, aminophosphine, carbene, amine or oxazoline ligand.
  • Transition metal catalysts containing chiral ligands are well known in the art and include those used for stereoselective hydrogenations, transmetalation and other bond forming reactions [a) Transition metals for organic synthesis , ed. M. Beller and C. Bolm, Wiley-VCH, New York, 2nd edn, 2005; b) J.
  • one enantiomer or diastereomer will be present in an amount greater than 50%. In a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 60%. In another embodiment, one enantiomer or diastereomer will be present in an amount greater than 70%. In a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 80%. In yet a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 90%. In another embodiment, one enantiomer or diastereomer will be present in an amount greater than 95%. In an embodiment, one enantiomer or diastereomer will be present in an amount greater than 99%.
  • HRMS-Cl and HRMS-ESI were performed on a Waters/Micromass GCT time-of-flight mass spectrometer and a Waters/Micromass Q-TOF Global quadrupole time-of-flight mass spectrometer respectively.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds of the formula Ia, formula Ib or formula IV from aldehydes of the formula II and boronic acids of the formula III or formula V, in the presence of ammonia or an ammonia equivalent of the formula NH4+X−.
Figure US08350047-20130108-C00001

Description

This application is a national phase entry of PCT/CA2008/000567, filed Mar. 28, 2008, which claims priority from U.S. Provisional patent application Ser. No. 60/909,000 filed Mar. 30, 2007.
FIELD OF THE APPLICATION
The present application relates to novel methods for the preparation of secondary carbinamine compounds, particularly the preparation of secondary carbinamine compounds from aldehydes and boronic acids in the presence of ammonia.
BACKGROUND OF THE APPLICATION
Amines are one of the most common classes of organic molecules. They play important roles in a variety of areas, ranging from the pharmaceutical industry to plastics manufacturing.
Current methods for the synthesis of amines generally rely on multi-step processes that convert a variety of amine precursors to the amino (NH2) functional group itself. To date, with the singular exception of two existing methodologies, there has been no general method for the direct synthesis of amines from ammonia. Since ammonia is an inexpensive bulk commodity chemical that is manufactured on a multi-ton scale annually, any process that allows for the direct use of ammonia for the introduction of the amino group is therefore highly desirable.
Research into the addition of allyl organometallics to carbonyl compounds and their derivatives continues to proceed unabated—a consequence of the fact that the resulting homoallylic products have proven to be valuable synthons [Denmark, S. E. and Almstead, N. G., Modern Carbonyl Chemistry, ed. Otera, J. Wiley-VCH, Weinheim, 2000, ch. 10; Yamamoto, Y. and Asao, N., Chem. Rev., 1993, 93, 2207; and Roush, W. R., Comprehensive Organic Synthesis, ed. Trost, B. M., Fleming, I. and Heathcock, C. H., Pergamon, Oxford, 2nd edn., 1991, vol. 2, pp 1-53]. The majority of the research, however, has focused on the addition of allylboronic esters to aldehydes. For example, the reaction of
Figure US08350047-20130108-C00002

has previously been described by Kobayashi et al. [M. Sugiura, K. Hirano and S. Kobayashi, J. Am. Chem. Soc., 2004, 126, 7182-7183; S. Kobayashi, K. Hirano and M. Sugiura, J. Chem. Commun., 2005, 104-105].
A methodology for the diastereoselective addition of allyl- and crotyl-boronic acids to ketones in the presence of methanolic ammonia to produce tertiary homoallylic amines was recently reported [Dhudshia, B., Tiburcio, J. and Thadani, A. N. Chem. Commun. 2005, 5551-5553].
SUMMARY OF THE APPLICATION
Methods for the direct addition of a variety of nucleophiles to aldehydes in the presence of ammonia have been shown to afford the corresponding secondary carbinamine compounds in moderate to excellent yields under mild reaction conditions. The methods have been shown to be simple and efficient for the incorporation of ammonia into the carbinamine end-products.
Accordingly, the present application includes a method of preparing a secondary amine of the formula Ia and/or Ib:
Figure US08350047-20130108-C00003

wherein
R1 is selected from C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alknyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R2 to R6 are independently selected from H, C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, the latter 9 groups being optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R7 and R8 are independently selected from H, C1-20alkyl, C3-20cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted; comprising reacting a compound of formula II:
Figure US08350047-20130108-C00004

wherein R1 is as defined for the compounds of formulae Ia and Ib, with a compound of formula III:
Figure US08350047-20130108-C00005

wherein R2-R6 are as defined for the compounds of formulae Ia and Ib, in the presence of ammonia NH3 or an ammonia equivalent of the formula NH4 +X, wherein X is an anionic counterion, and optionally isolating the amine of the formula Ia and/or Ib.
In another aspect, the present application relates to a method of preparing an amine of the formula IV:
Figure US08350047-20130108-C00006

wherein
R1 is selected from C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R10 is aryl or heteroaryl, both of which are optionally substituted; and
R7 and R8 are independently selected from H, C1-20alkyl, C2-20alkynyl, C3-20cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted; comprising reacting a compound of the formula II:
Figure US08350047-20130108-C00007

wherein R1 is as defined for the compounds of formula IV, with a compound of the formula V:
Figure US08350047-20130108-C00008

wherein R10 is as defined for the compound of formula IV, in the presence of ammonia NH3 or an ammonia equivalent of the formula NH4 +X, wherein X is an anionic counterion, and optionally isolating the amine of the formula IV.
It is an embodiment of the present application that the method of preparing the compounds of the formulae Ia, Ib and IV is performed in the presence of a catalyst, such as a transition metal catalyst. In a further embodiment, the catalyst comprises a chiral ligand and its use results in the preparation of enantiomerically enriched compounds of formulae Ia, Ib and IV.
Other features and advantages of the present application will become apparent from the following detailed description. It should be understood, however, that the detailed description and the specific examples while indicating preferred embodiments of the application are given by way of illustration only, since various changes and modifications within the spirit and scope of the application will become apparent to those skilled in the art from this detailed description.
DETAILED DESCRIPTION OF THE APPLICATION Definitions
The term “C1-nalkyl” as used herein means straight and/or branched chain alkyl groups containing from one to n carbon atoms and includes, depending on the identity of n, methyl, ethyl, propyl, isopropyl, t-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, hexadecyl, octadecyl, icosyl and the like and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “C3-ncycloalkyl” as used herein means saturated cyclic or polycyclic alkyl groups containing from three to n carbon atoms and includes, depending on the identity of n, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl, cycloundecyl, cyclododecyl, cyclohexadecyl, cyclooctadecyl, cycloicosyl, adamantyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “C1-nalkoxy” as used herein means straight and/or branched chain alkoxy groups containing from one to n carbon atoms and includes, depending on the identity of n, methoxy, ethoxy, propoxy, isopropoxy, t-butoxy, pentoxy, hexoxy, heptoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, hexadecoxy, octadecoxy, icosoxy and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “C3-ncycloalkoxy” as used herein means saturated cyclic or polycyclic alkoxy groups containing from three to n carbon atoms and includes, depending on the identity of n, cyclopropoxy, cyclobutoxy, cyclopentoxy, cyclohexoxy, cycloheptoxy, cyclooctoxy, cyclononoxy, cyclodecoxy, cycloundecoxy, cyclododecoxy, cyclohexadecoxy, cyclooctadecoxy, cycloicosoxy and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “C2-nalkenyl” as used herein means straight and/or branched chain alkenyl groups containing from two to n carbon atoms and one to six double bonds and includes, depending on the identity of n, vinyl, allyl, 1-butenyl, 2-hexenyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “C2-nalkynyl” as used herein means straight or branched chain alkynyl groups containing from 2 to n carbon atoms and one to six triple bonds and includes, depending on the identity of n, propargyl, 1-butynyl, 2-hexynyl and the like, and wherein n is an integer representing the maximum number of carbon atoms in the group.
The term “halo-substituted C1-nalkyl” as used herein means straight or branched chain, saturated alkyl radicals containing from one to n carbon atoms in which one or all of the hydrogen atoms have been replaced with a halogen, in particular fluorine, and includes (depending on the identity of “n”) trifluoromethyl, pentafluoroethyl, fluoromethyl and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkyl radical.
The term “halo-substituted C1-nalkoxy” as used herein means straight or branched chain, saturated alkoxy radicals containing from one to n carbon atoms in which one or all of the hydrogen atoms have been replaced with a halogen, in particular fluorine, and includes (depending on the identity of “n”) trifluoromethoxy, pentafluoroethoxy, fluoromethoxy and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkoxy radical.
The term “aryl” as used herein means a monocyclic or polycyclic carbocyclic ring system containing one or two aromatic rings and from 6 to 14 carbon atoms and includes phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl and the like.
The term “heteroaryl” as used herein means mono- or polycyclic heteroaromatic radicals containing from 5 to 14 atoms, of which 1 to 4 atoms are a heteroatom selected from nitrogen, oxygen and sulfur and includes furanyl, thienyl, pyrrolo, pyridyl, indolo, benzofuranyl and the like.
The term “halo” as used herein means halogen and includes chloro, fluoro, bromo and iodo.
The term “one or more” as used herein means that from one to the maximum allowable substitutions are allowed.
The term “optionally substituted” means unsubstituted or substituted. When a group is substituted it may be substituted one or more times, one to five times, one to three times, one to two times or one time.
The term “ammonia equivalent” as used here refers to a compound that reacts in situ to produce an equivalent of “NH3” or ammonia.
The term “enantiomerically enriched” as used herein means a mixture of enantiomeric compounds that contains an excess of one enantiomer over the other(s).
The present application includes combinations of groups and substituents that are permitted and would provide a stable chemical entity according to standard chemical knowledge as would be known to those skilled in the art.
Methods of the Application
A new method for the preparation of secondary carbinamine compounds from the diastereoselective allylation and crotylation of aldehydes in the presence of ammonia has been developed. The method has been shown to provide the homoallylic amines in high yields through simple acid-base extraction.
Accordingly, the present application relates to a method of preparing a secondary amine of the formula Ia and/or Ib:
Figure US08350047-20130108-C00009

wherein
R1 is selected from C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alknyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R2 to R6 are independently selected from H, C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, the latter 9 groups being optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R7 and R8 are independently selected from H, C1-20alkyl, C3-20cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted;
comprising reacting a compound of formula II:
Figure US08350047-20130108-C00010

wherein R1 is as defined for the compounds of formula Ia and Ib, with a compound of formula III:
Figure US08350047-20130108-C00011

wherein R2-R6 are as defined for the compounds of formulae Ia and Ib, in the presence of ammonia NH3 or an ammonia equivalent of the formula NH4 +X, wherein X is an anionic counterion, and optionally isolating the amine of the formulae Ia and/or Ib.
It is an embodiment of the application that the compounds of formulae Ia, Ib and II include those in which R1 is selected from C1-10alkyl, C3-8cycloalkyl, aryl, and heteroaryl, all of which are optionally substituted. In another embodiment of the application, one or more of the carbons in C1-10alkyl or C3-8cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8, in which R7 and R8 are independently selected from H and C1-6alkyl. Suitably, one or more of the carbons in C1-18alkyl or C3-8cycloalkyl is optionally replaced with a heteroatom selected from O and S.
It is another embodiment of the application that the optional substituents on R1 in the compounds of the formulae Ia, Ib and II are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted C1-6alkyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C2-8alkenyl, C2-8alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl. Particularly, in an embodiment of the application, the optional substituents on R1 in the compounds of the formulae Ia, Ib and II are independently selected from one to three of OH, F, Cl, Br, CN, NO2, CF3, OCF3, C1-4alkyl, C1-4alkoxy, phenyl, benzyl, benzyloxy and C(O)OC1-4alkyl.
It is an embodiment of the application that R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H, C1-10alkyl, C3-12cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted. In another embodiment of the application, one or more of the carbons in C1-10alkyl or C3-10cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8, in which R7 and R8 are independently selected from H and C1-6alkyl. Suitably, one or more of the carbons in C1-10alkyl or C3-8cycloalkyl is optionally replaced with a heteroatom selected from O and S. In a particular embodiment of the application, R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H and C1-6alkyl. In a more particular embodiment of the application, R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H and methyl.
In another embodiment of the application, the optional substituents on R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted C1-6alkyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C2-6alkenyl, C2-6alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
In an embodiment of the application, the method of preparing compounds of the formulae Ia and/or Ib is performed in the presence of ammonia. In yet another embodiment of the application, the method of preparing compounds of the formulae Ia and/or Ib is performed in the presence of an ammonia salt NH4 +X in which X is an anionic counterion. In a further embodiment of the application, X is selected from halo, R9COO, R9SO4 and BF4, in which R9 is selected from C1-10alkyl, C3-20cycloalkyl, aryl and heteroaryl, all of which are optionally substituted. In an embodiment of the application, X is Cl or Br. In a still further embodiment of the application, the optional substituents on R9 are independently selected from one or more of OH, halo, CN, NO2, phenyl, benzyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C1-6alkyl, halo-substituted C1-6alkyl, C2-6alkenyl, C2-6alkenyloxy, NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
In an embodiment of the application, the method of preparing compounds of formulae Ia and/or Ib is performed in a suitable solvent. More particularly, the solvent is selected from selected from selected from methanol, ethanol, propanol, butanol, toluene, tetrahydrofuran, acetonitrile, benzene, dioxane, methylene chloride, liquid ammonia, ionic liquids and mixtures thereof.
In an embodiment of the application, the method of preparing compounds of formulae Ia and/or Ib is performed by combining an alcoholic solution of ammonia, or an ammonia equivalent in a suitable solvent, with the compound of formula II. The ammonia or ammonia equivalent is suitably used in molar excess amounts, for example about 5 to about 20 molar equivalents, relative to the amount of the compound of formula II. Once the ammonia or ammonia equivalent has reacted with the compound of formula II for a sufficient period of time (determinable by a person skilled in the art, for example by following the reaction using thin layer chromatography and observing the disappearance of the compound of formula II), the compound of formula III may be added to the combined solution of ammonia or ammonia equivalent and compound of formula II. The compound of formula III may be used in molar excess amounts, for example about 1.1 to about 5 molar equivalents, suitably about 1.2 to 2.5 molar equivalents, relative to the amount of the compound of formula II.
It is an embodiment of the application that the method of preparing compounds of formulae Ia and/or Ib is performed at room temperature or above or below room temperature, for example, at a temperature of from −40° C. to +100° C., suitably from 0° C. to 50° C., more suitably from 10° C. to 30° C. In an embodiment of the application, the method is performed at room temperature.
A person skilled in the art would appreciate that the reaction conditions, including for example, temperature, time and reactant ratios, may vary depending on a number of variables, including, but not limited to, the structure of the starting materials (compounds of formulae II and III), the solvent, presence or absence of a catalyst (vide supra) and the reaction pressure. A person skilled in the art would be able to optimize the reaction conditions to obtain the best yields and overall performance of the reaction based on the results presented herein and methods known in the art. Reaction progress may be monitored using known techniques, for example, thin layer chromatography, high performance liquid chromatography and/or NMR spectroscopy, to determine optimum reaction conditions.
The compounds of the formulae Ia and/or Ib may optionally be isolated using standard methods known in the art, for example, by acid/base extraction methods. Further purification steps may be performed, for example, chromatography, and if R2 and R3 are different, chiral resolution. Chiral resolution of enantiomers may be performed, for example, by forming chiral esters or salts, followed by separation of the diastereomers using crystallization or chromatographic techniques, and liberation of the free amine.
A new method for the preparation of secondary carbinamine compounds from the diastereoselective arylation of aldehydes in the presence of ammonia has also been developed. The method has been shown to provide the aryl amines in high yields through simple acid-base extraction.
Accordingly, in another aspect, the present application relates to a method of preparing an amine of the formula IV:
Figure US08350047-20130108-C00012

wherein
R1 is selected from C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R10 is aryl or heteroaryl, both of which are optionally substituted; and
R7 and R8 are independently selected from H, C1-20alkyl, C2-20alkynyl, C3-20cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted;
comprising reacting a compound of the formula II:
Figure US08350047-20130108-C00013

wherein R1 is as defined for the compounds of formula IV, with a compound of the formula V:
Figure US08350047-20130108-C00014

wherein R10 is as defined for the compound of formula IV, in the presence of ammonia NH3 or an ammonia equivalent of the formula NH4 +X, wherein X is an anionic counterion, and optionally isolating the amine of the formula IV.
It is an embodiment of the application that R1 in the compounds of the formulae II and IV is selected from C1-10alkyl, aryl and heteroaryl, all of which are optionally substituted. In another embodiment of the application, one or more of the carbons in C1-10alkyl is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8, in which R7 and R8 are independently selected from H and C1-6alkyl. Suitably, one or more of the carbons in C1-10alkyl is optionally replaced with a heteroatom selected from O and S.
In an embodiment of the application, the optional substituents on R1 in the compounds of the formulae II and IV are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted alkyl, C1-6alkoxy, halo-substituted alkoxy, C2-6alkenyl, C2-6alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl. More particularly, in an embodiment of the application, the optional substituents on R1 in the compounds of the formulae II and V are independently selected from one to three of OH, F, Cl, Br, CN, NO2, CF3, OCF3, C1-4alkyl, C1-4alkoxy, phenyl, benzyl, benzyloxy and C(O)OC1-4alkyl.
It is an embodiment of the application that R10 in the compounds of the formulae IV and V is selected from phenyl, naphthyl, anthraceneyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl, furanyl, thienyl, pyrrolo, pyridyl, indolo and benzofuranyl, all of which are optionally substituted. In a particular embodiment of the application, R10 in the compounds of the formulae IV and V is optionally substituted phenyl.
In an embodiment of the application, the optional substituents on R10 in the compounds of the formulae IV and V are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted alkyl, C1-6alkoxy, halo-substituted alkoxy, C2-6alkenyl, C2-6alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl. Particularly, in an embodiment of the application, the optional substituents on R10 in the compounds of the formulae IV and V are independently selected from on to three of OH, F, Cl, Br, CN, NO2, CF3, OCF3, C1-4alkyl, C1-4alkoxy, phenyl, benzyl, benzyloxy and C(O)OC1-4alkyl.
In an embodiment of the application, the method of preparing compounds of formula IV is performed in the presence of ammonia. In yet another embodiment of the application, the method of preparing compounds of formula IV is performed in the presence of an ammonia salt NH4 +X in which X is an anionic counter ion. In a further embodiment of the application, X is selected from halo, R9COO, R9SO4 and BF4, in which R9 is selected from C1-10alkyl, C3-20cycloalkyl, aryl and heteroaryl, all of which are optionally substituted. In an embodiment of the application, X is Cl or Br. In a still further embodiment of the application, the optional substituents on R9 are independently selected from one or more of OH, halo, CN, NO2, phenyl, benzyl, C1-6alkoxy, halo-substituted alkoxy, C1-6alkyl, halo-substituted alkyl, C2-6alkenyl, C2-6alkenyloxy, NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
In an embodiment of the application, the method of preparing compounds of formula IV is performed in a solvent. More particularly, the solvent is selected from selected from methanol, ethanol, propanol, butanol, toluene, tetrahydrofuran, acetonitrile, benzene, dioxane, methylene chloride, liquid ammonia, ionic liquids and mixtures thereof.
In an embodiment of the application, the method of preparing compounds of formula IV is performed by combining an alcoholic solution of ammonia, or an ammonia equivalent in a suitable solvent, with the compound of formula II. The ammonia or ammonia equivalent is suitably used in molar excess amounts, for example about 5 to about 20 molar equivalents, relative to the amount of the compound of formula II. Once the ammonia or ammonia equivalent has reacted with the compound of formula II for a sufficient period of time (determinable by a person skilled in the art, for example by following the reaction using thin layer chromatography and observing the disappearance of the compound of formula II), the compound of formula III may be added to the combined solution of ammonia or ammonia equivalent and compound of formula II. The compound of formula V may be used in molar excess amounts, for example about 1.1 to about 5 molar equivalents, suitably about 1.2 to 2.5 molar equivalents, relative to the amount of the compound of formula II.
In another embodiment of the present application, the method of preparing compounds of formula IV is performed at a temperature of from about −40° C. to about +150° C. More suitably, in an embodiment of the application, the method is performed at a temperature of from about +50° C. to about +120° C. It is an embodiment of the application that the method is performed at a temperature of about 80° C.
A person skilled in the art would appreciate that the reaction conditions, including for example, temperature, time and reactant ratios, may vary depending on a number of variables, including, but not limited to, the structure of the starting materials (compounds of formulae II and V), the solvent, presence or absence of a catalyst and the reaction pressure. A person skilled in the art would be able to optimize the reaction conditions to obtain the best yields and overall performance of the reaction based on the results presented herein and methods known in the art. Reaction progress may be monitored using known techniques, for example, thin layer chromatography, high performance liquid chromatography and/or NMR spectroscopy, to determine optimum reaction conditions.
The compounds of the formula IV may optionally be isolated using standard methods known in the art, for example, by acid/base extraction methods. Further purification steps may be performed, for example, chromatography, and if R1 and R10 are different, chiral resolution. Chiral resolution of enantiomers may be performed, for example, by forming chiral esters or salts, followed by separation of the diastereomers using crystallization or chromatographic techniques, and liberation of the free amine.
It is an embodiment of the application that the methods for preparing compounds of formula Ia, Ib and/or IV are performed in the presence of a catalyst, in particular a transition metal catalyst. Particularly, in an embodiment of the application, the catalyst is any of the well-known transition metal catalysts. In a further embodiment of the application, the metal is selected from rhodium, ruthenium, iridium, copper, platinum, palladium and nickel. In a still further embodiment of the application, the metal is rhodium. The catalyst may be included in the method, for example, by adding it along with the compound of formula III or V, either by a separate addition or in a combined solution with the compound of formula III or V.
In an embodiment of the present application, when a catalyst is used, it is added in amounts of about 1 mol % to about 20 mol %, suitably about 5 mol % to about 10 mol %, based on the amount of the aldehyde.
In another embodiment of the application, the metal catalyst possesses at least one chiral or achiral ligand. In another embodiment, the ligand is a phosphine, diphosphine, aminophosphine, carbene, amine or oxazoline ligand. Transition metal catalysts containing chiral ligands are well known in the art and include those used for stereoselective hydrogenations, transmetalation and other bond forming reactions [a) Transition metals for organic synthesis, ed. M. Beller and C. Bolm, Wiley-VCH, New York, 2nd edn, 2005; b) J. Tsuji in Transition metal reagents and catalysts: innovations in organic synthesis, John Wiley & Sons, New York, 2000]. By performing the methods described herein in the presence of a chiral catalyst, stereoselective additions of the compounds of formula II to the compounds of formula III, or the compounds of formulae II to the compounds of formula V, are achieved. Accordingly, compounds of formulae Ia, Ib and IV may be prepared in enantioselective and/or diastereoselective manner. In an embodiment, when a transition metal catalysts comprising a chiral ligand is used, an enantiomerically or diasteromerically enriched compound is obtained, i.e. one enantiomer or diastereomer will be present in an amount greater than 50%. In a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 60%. In another embodiment, one enantiomer or diastereomer will be present in an amount greater than 70%. In a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 80%. In yet a further embodiment, one enantiomer or diastereomer will be present in an amount greater than 90%. In another embodiment, one enantiomer or diastereomer will be present in an amount greater than 95%. In an embodiment, one enantiomer or diastereomer will be present in an amount greater than 99%.
The following non-limiting examples are illustrative of the present application:
EXAMPLES Materials and Methods
All reagents were used as received (Aldrich, Acros, Strem). Methanol was dried over magnesium methoxide and distilled prior to use. Allyl (E)- and (Z)-crotylboronic acid in anhydrous methanol (2 M solution) were prepared just prior to use (exact molarities were confirmed by titration with benzaldehyde) [H. C. Brown, U. S. Racherla and P. J. Pellechia, J. Org. Chem., 1990, 55, 1868].
Melting points were uncorrected and were measured on a Fisher-Johns melting point apparatus. 1H and 13C NMR were recorded at 300 or 500 MHz and 75 or 125 MHz respectively on a Bruker Spectrospin 300 or 500 MHz spectrometer. Proton chemical shifts were internally referenced to the residual proton resonance in CDCl3 (δ 7.26). Carbon chemical shifts were internally referenced to the deuterated solvent signals in CDCl3 (δ 77.00). Infrared spectra were obtained on a Bruker VECTOR22FT-IR spectrometer. HRMS-Cl and HRMS-ESI were performed on a Waters/Micromass GCT time-of-flight mass spectrometer and a Waters/Micromass Q-TOF Global quadrupole time-of-flight mass spectrometer respectively.
Example 1 General Procedure for the Allylation of Aldehydes with Allylboronic Acid in the Presence of Ammonia
A solution of ammonia (ca. 7N in MeOH, 0.75 mmol, ca. 10 equiv.) was added to the aldehyde (1) (0.5 mmol). The resulting solution was stirred for 15 minutes at room temperature, followed by the addition of a freshly prepared solution of allylboronic acid (2) (2M in MeOH, 0.4 mL, 0.80 mmol) dropwise over 5 minutes. The reaction mixture was subsequently stirred for 1 hour at room temperature. The volatiles were removed in vacuo and the residue re-dissolved in Et2O (15 mL). Aqueous HCl (1N, 15 mL) was then added dropwise to the residue. The biphasic mixture was vigorously shaken, and the layers were separated. The acidic aqueous layer was washed with Et2O (3×15 mL), and made basic by the addition of solid NaOH (ca. 5 g). The aqueous layer was then extracted with CH2Cl2 (3×15 mL). The combined organic extracts were dried with Na2SO4, filtered and concentrated in vacuo to afford the desired secondary carbinamine (3). Table 1 summarizes the various aldehydes that were converted to carbinamines and the respective yields.
(i) 1-(Benzyloxy)pent-4-en-2-amine (3a)
Figure US08350047-20130108-C00015
3a isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.32-7.20 (5H, m), 5.84-5.67 (1H, m), 5.12-5.00 (2H, m), 4.83 (2H, s), 3.41 (1H, dd, J=9.0, 4.5 Hz), 3.24 (1H, dd, J=9.0, 7.5 Hz), 3.08-2.97 (1H, m), 2.25-2.15 (1H, m), 2.08-1.94 (1H, m), 1.37 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 138.09, 134.98, 128.10, 127.35, 127.32, 117.16, 75.07, 72.95, 50.15, 38.59; HRMS (ESI) m/z calcd. for C12H18NO (MH+) 192.1388, found 192.1384.
(ii) 1-(4-Methoxyphenyl)but-3-en-1-amine (3b)
Figure US08350047-20130108-C00016
3b isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.23 (2H, d, J=8.5 Hz), 6.84 (2H, d, J=8.5 Hz), 5.80-5.64 (1H, m), 5.13-5.00 (2H, m), 3.92 (1H, dd, J=8.0, 5.5 Hz), 3.76 (3H, s), 2.46-2.24 (2H, m), 1.48 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 158.41, 137.89, 135.49, 127.18, 117.30, 113.60, 5.08, 54.65, 44.17; HRMS (Cl) m/z calcd. for C11H16NO (MH+) 178.1232, found 178.1227.
(iii) Undec-1-en-4-amine (3c)
Figure US08350047-20130108-C00017
3c isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 5.82-5.65 (1H, m), 5.09-4.98 (2H, m), 2.77-2.68 (1H, m), 2.23-2.12 (1H, m), 1.99-1.88 (1H, m), 1.43-1.15 (14H, m), 0.84 (3H, t, J=7.0 Hz); 13C NMR (CDCl3, 75 MHz) δ 135.92, 117.06, 50.53, 42.56, 27.65, 31.77, 29.65, 29.23, 26.19, 22.58, 14.01; HRMS (Cl) m/z calcd. for C11H24N (MH+) 170.1909, found 170.1905.
(iv) 2,2-dimethylhex-5-en-3-amine (3d)
Figure US08350047-20130108-C00018
3d isolated as a clear, colorless oil: 1H NMR (CDCl3, 500 MHz) δ 5.83-5.73 (1H, m), 5.06 (1H, dd, J=17.0, 1.5 Hz), 5.04 (1H, dd, J=10.0, 1.5 Hz), 2.42 (1H, dd, J=10.5, 2.5 Hz), 2.38-2.30 (1H, m), 1.76-1.67 (1H, m), 1.11 (2H, br s), 0.87 ((9H, s); 13C NMR (CDCl3, 125 MHz) δ 137.71, 116.62, 59.47, 36.87, 26.09; HRMS (Cl) m/z calcd. for C8H18N (MH+) 128.1439, found 128.1437.
(v) 1-phenylhex-5-en-3-amine (3e)
Figure US08350047-20130108-C00019
3e isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.31-7.09 (5H, m), 5.87-5.69 (1H, m), 5.10 (1H, d, J=17.0 Hz), 5.09 (1H, d, J=11.0 Hz), 2.90-2.55 (3H, m), 2.33-2.20 (1H, m), 2.03 (1H, dt, J=13.5, 7.5 Hz), 1.83-1.55 (2H, m), 1.29 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 142.18, 135.57, 128.29 (two signals overlapped), 125.70, 117.38, 50.10, 42.59, 39.31, 32.58.
(vi) 1-cyclohexylbut-3-en-1-amine (3f)
Figure US08350047-20130108-C00020
3f isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 5.73 (1H, dddd, J=17.0, 10.5, 8.0, 6.0 Hz), 5.01 (1H, d, J=17.0 Hz), 4.99 (1H, d, J=10.5 Hz), 2.53-2.43 (1H, m), 2.25-2.15 (1H, m), 1.88 (1H, dt, J=13.5, 8.5 Hz), 1.64-1.42 (5H, m), 1.24-0.87 (8H, m); 13C NMR (CDCl3, 75 MHz) δ 136.65, 116.94, 55.30, 43.47, 39.46, 29.68, 28.28, 26.62, 26.49, 26.37.
(vii) 1-(3-methoxyphenyl)but-3-en-1-amine (3g)
Figure US08350047-20130108-C00021
3g isolated as a low melting point solid: m.p.=30° C. (EtOAc); 1H NMR (CDCl3, 300 MHz) δ 7.23 (1H, t, J=8.5 Hz), 6.95-6.87 (2H, m), 6.77 (1H, ddd, J=8.5, 2.5, 1.0 Hz), 5.74 (1H, dddd, J=17.0, 10.0, 8.0, 6.5 Hz), 5.11 (1H, J=17.0 Hz), 5.07 (1H, d, J=10.0 Hz), 4.00-3.92 (1H, m), 3.79 (3H, s), 2.45 (1H, dt, J=13.5, 6.0 Hz), 2.31 (1H, dt, J=13.5, 8.0 Hz), 1.57 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 159.67, 147.60, 135.36, 129.32, 118.61, 117.56, 112.25, 111.84, 55.28, 55.13, 44.09.
(viii) 4-(1-aminobut-3-enyl)benzonitrile (3h)
Figure US08350047-20130108-C00022
3h isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.54 (1H, d, J=8.5 Hz), 7.41 (1H, d, J=8.5 Hz), 5.65 (1H, dddd, J=17.5, 10.5, 8.0, 6.5 Hz), 5.10-4.98 (2H, m), 4.01 (1H, dd, J=8.0, 5.5 Hz), 2.36 (1H, ddd, J=14.0, 6.5, 5.5 Hz), 2.26 (1H, dt, J=14.0, 8.0 Hz), 1.52 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 151.35, 134.44, 132.22, 127.29, 118.98, 118.46, 110.67, 55.06, 44.03.
(ix) 1-(pyridin-2-yl)but-3-en-1-amine (3i)
Figure US08350047-20130108-C00023
3i isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 8.47 (1H, br s), 7.54 (1H, dt, J=7.5, 1.5 Hz), 7.22 (1H, d, J=8.0 Hz), 7.05 (1H, dd, J=7.5, 5.5 Hz), 5.69 (1H, dddd, J=17.5, 10.0, 7.5, 6.5 Hz), 5.01 (1H, d, J=17.5 Hz), 4.98 (1H, d, J=10.0 Hz), 3.96 (1H, t, J=7.5 Hz), 2.57-2.44 (1H, m), 2.30 (1H, dt, J=13.5, 8.0 Hz), 1.71 (2H, br s); 13C NMR (CDCl3, 75 MHz) δ 163.95, 148.95, 136.21, 135.02, 121.71, 120.76, 117.54, 56.32, 43.09.
(x) 1-(1H-indol-3-yl)but-3-en-1-amine (3j)
Figure US08350047-20130108-C00024
3j isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) d8.94 (1H, br s), 7.73 (1H, d, J=7.5 Hz), 7.31 (1H, d, J=8.0 Hz), 7.24-7.10 (2H, m), 7.02 (1H, d, J=2.0 Hz), 5.96-5.80 (1H, m), 5.25-5.10 (2H, m), 4.41 (1H, dd, J=8.0, 5.0 Hz), 2.80-2.69 (1H, m), 2.60-2.47 (1H, m), 1.80 (2H, br s); 13C NMR (CDCl3, 75 MHz) d 136.47, 135.83, 125.83, 121.77, 120.66, 120.26, 119.10, 118.95, 117.38, 111.29, 47.91, 42.98.
Discussion
The addition of allylboronic acid (2) to aldehydes, when first pretreated with ammonia, has been found to lead cleanly and efficiently to the formation of the corresponding secondary carbinamines under mild reaction conditions. As seen in Table 1, the resulting secondary carbinamines were easily isolated and uniformly obtained in high yields through standard acid-base extraction, and did not require any subsequent chromatographic purification.
Example 2 General Procedure for the Crotylation of Aldehydes with (E) or (Z)-Crotylboronic Acid in the Presence of Ammonia
A solution of ammonia (ca. 7N in MeOH, 0.75 mmol, ca. 10 equiv.) was added to the aldehyde (1) (0.5 mmol). The resulting solution was stirred for 15 minutes at room temperature, followed by the addition of a freshly prepared solution of either (E) or (Z)-crotylboronic acid (4a) or (4b) (2M in MeOH, 0.4 mL, 0.80 mmol) dropwise over 5 minutes. The reaction mixture was subsequently stirred for 1 hour at room temperature. The volatiles were removed in vacuo and the residue re-dissolved in Et2O (15 mL). Aqueous HCl (1N, 15 mL) was then added dropwise to the residue. The biphasic mixture was vigorously shaken, and the layers were separated. The acidic aqueous layer was washed with Et2O (3×15 mL), and made basic by the addition of solid NaOH (ca. 5 g). The aqueous layer was then extracted with CH2Cl2 (3×15 mL). The combined organic extracts were dried with Na2SO4, filtered and concentrated in vacuo to afford the desired secondary carbinamine (5). Table 2 summarizes the various aldehydes that were converted to carbinamines using (E) or (Z)-crotylboronic acid and the respective yields and diastereomeric ratios (d.r.).
(i) (2S,3S)-1-(benzyloxy)-3-methylpent-4-en-2-amine (5a)
Figure US08350047-20130108-C00025
5a isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.35-7.22 (5H, m), 5.78-5.65 (1H, m), 5.09-5.00 (2H, m), 4.51 (2H, br s), 3.50 (1H, dd, J=9.0, 4.0 Hz), 3.32 (1H, dd, J=9.0, 7.5 Hz), 2.92-2.77 (1H, m), 2.23 (1H, hextet, J=7.0 Hz), 1.36 (2H, br s), 1.00 (3H, d, J=7.0 Hz); 13C NMR (CDCl3, 75 MHz) δ 140.70, 138.27, 128.25, 127.52, 127.46, 115.34, 73.61, 73.16, 54.82, 41.15, 16.74; HRMS (Cl) m/z calcd. for C13H20NO (MH+) 206.1545, found 206.1550.
(ii) (1S,2S)-1-(4-Methoxyphenyl)-2-methylbut-3-en-1-amine (5b)
Figure US08350047-20130108-C00026
5b isolated as a clear, colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.20 (2H, d, J=8.5 Hz), 6.83 (2H, d, J=8.5 Hz), 5.71 (1H, ddd, J=17.5, 10.0, 8.5 Hz), 5.13 (1H, dd, J=17.5, 2.0 Hz), 5.07 (1H, dd, J=10.0, 2.0 Hz), 3.76 (3H, s), 3.56 (1H, d, J=8.0 Hz), 3.29 (1H, hextet, J=7.0 Hz), 1.48 (2H, br s), 0.78 (3H, d, J=7.0 Hz); 13C NMR (CDCl3, 75 MHz) δ 158.46, 141.76, 136.54, 128.07, 115.47, 113.42, 59.86, 55.01, 46.35, 17.49; HRMS (Cl) m/z calcd. for C13H20NO (MH+) 206.1545, found 206.1550.
(iii) (1S,2R)-1-(4-Methoxyphenyl)-2-methylbut-3-en-1-amine (5c)
Figure US08350047-20130108-C00027
(iv) (1S,2R)-1-(1H-indol-3-yl)-2-methylbut-3-en-1-amine (5d)
Figure US08350047-20130108-C00028
5d isolated as a clear, colorless oil: 1H NMR (CDCl3, 500 MHz) d 8.82 (1H, br s), 7.71 (1H, d, J=8.0 Hz), 7.32 (1H, d, J=8.0 Hz), 7.22 (1H, t, J=7.0 Hz), 7.16 (1H, t, J=7.0 Hz), 7.04 (1H, d, J=2.0 Hz), 5.94 (1H, ddd, J=17.5, 10.5, 7.0 Hz), 5.16 (1H, dd, J=17.5, 1.5 Hz), 5.10 (1H, dd, J=10.5, 1.5 Hz), 4.37 (1H, d, J=5.0 Hz), 2.78 (1H, J=5.5 Hz), 1.68 (2H, br s), 1.07 (3H, d, J=7.0 Hz); 13C NMR (CDCl3, 125 MHz) d 141.75, 136.37, 126.40, 121.70, 121.59, 119.35, 119.18, 119.09, 114.61, 111.18, 52.87, 43.69, 14.72.
Discussion
The addition of (E) or (Z)-crotyltrifluoroborate (4a) or (4b) to aldehydes, when first pretreated with ammonia, has been found to lead cleanly and efficiently to the formation of the corresponding secondary carbinamines under mild reaction conditions as seen in Table 2. Excellent diastereoselectivities were observed with all the tested substrates, in which the (E)-crotyl reagent (4a) afforded the anti-homoallylic amine, and the (Z)-crotyl reagent (4b) afforded the syn-homoallylic amine. The resulting secondary carbinamines were easily isolated and uniformly obtained in high yields through standard acid-base extraction, and did not require any subsequent purification.
Example 3 General Procedure for the Rhodium-Catalyzed Addition of Aryl and Alkenylboronic Acids to Aldehydes in the Presence of Ammonia
A saturated solution of ammonia in 1,4-dioxane (2 mL) was added to the aldehyde (6). To the resulting solution was added freshly prepared boronic acid (8) (1.0 mmol) and Rh(acac)(CO)2 (12.9 mg, 0.05 mmol). Distilled water (0.4 mL) was then added to the solution and the reaction mixture was heated to 80° C. in a sealed tube for 16 h. The reaction mixture was then cooled to room temperature and the volatiles were removed in vacuo. The residue was dissolved in CH2Cl2 (20 mL) and washed with saturated aq. NaHCO3 (10 mL). The organic layer was dried (Na2SO4), filtered and concentrated in vacuo to afford a yellow oil, which was then subjected to silica gel chromatography (EtOAc/hexanes/Et3N) to afford the carbinamine (8). In some cases, the resulting carbinamine (8) was treated with HCl (1.0 Min Et2O) to afford the corresponding hydrochloride salt. The salt was then isolated by filtration.
(i) (4-bromophenyl)(phenyl)methanamine (8a)
Figure US08350047-20130108-C00029
8a isolated as a clear, colourless oil. 1H NMR (CD3OD, 300 MHz) d 7.55 (2H, d, J=8.5 Hz), 7.50-7.13 (7H, m), 5.48 (1H, s), 1.80 (2H, br s).
(ii) Phenyl(4-(trifluoromethyl)phenyl)methanaminium chloride (8b)
Figure US08350047-20130108-C00030
8b isolated as a white solid: mp=231-234° C.; 1H NMR (500 MHz, CD3OD) δ 7.78 (2H, d, J=8.0 Hz), 7.64 (1H, s), 7.62 (1H, d, J=0.5 Hz), 7.51-7.41 (5H, m), 5.79 (1H, s); 13C NMR (125 MHz, CD3OD) δ 143.04, 138.05, 132.31 (q, J=32.0 Hz), 130.73, 130.50, 129.33, 128.78, 127.46 (q, J=4.0 Hz), 59.04.
(iii) naphthalen-2-yl(p-tolyl)methanaminium chloride (8c)
Figure US08350047-20130108-C00031
8c isolated as a white solid: mp=234-236° C.; 1H NMR (300 MHz, CD3OD) δ 7.97-7.90 (4H, m), 7.60-7.56 (2H, m), 7.47 (1H, dd, J=9.0, 2.0 Hz), 7.38 (2H, d, J=8.5 Hz), 7.31 (2H, d, J=8.0 Hz), 5.80 (1H, s), 2.39 (3H, s); 13C NMR (75 MHz, CD3OD) δ 138.90, 134.79, 134.24, 133.24, 129.52, 128.88, 127.94, 127.87, 127.46, 127.14, 126.73, 126.64, 125.86 124.38, 58.05, 19.83.
(iv) (4-chlorophenyl)(phenyl)methanaminium chloride (8d)
Figure US08350047-20130108-C00032
8d isolated as a white solid: m.p.=220-224° C.; 1H NMR (300 MHz, CD3OD) δ 7.48 (9H, s), 5.71 (1H, s); 13C NMR (75 MHz, CD3OD) δ 144.81, 136.92, 136.13, 134.51, 129.06, 128.97, 128.83, 128.74, 127.00, 120.26, 57.43.
Discussion:
The addition of aryl boronic acids (7) to aldehydes (6), when first pretreated with ammonia, led cleanly and efficiently to the formation of the corresponding secondary carbinamines under mild reaction conditions as seen in Table 3. The resulting secondary carbinamines were easily isolated and uniformly obtained in good yields.
Example 4 General Procedure for the Enantioselective Rhodium-Catalyzed Addition of Aryl- and Alkenylboronic Acids to Aldehydes in the Presence of Ammonia
A saturated solution of ammonia in 1,4-dioxane (2 mL) was added to the aldehyde. To the resulting solution was added freshly prepared boronic acid (1.0 mmol), Rh(acac)(CO)2 (6.5 mg, 0.025 mmol) and (2S,5S)-Duphos (8 mg, 0.025 mmol). Distilled and degassed water (0.4 mL) was then added to the solution and the reaction mixture was heated to 80° C. in a sealed tube for 16 h. The reaction mixture was then cooled to room temperature and the volatiles were removed in vacuo. The residue was dissolved in CH2Cl2 (20 mL) and washed with saturated aq. NaHCO3 (10 mL). The organic layer was dried (Na2SO4), filtered and concentrated in vacuo to afford a yellow oil, which was then subjected to silica gel chromatography (EtOAc/hexanes/Et3N) to afford the carbinamine (9). The enantioselectivities were measured by chiral HPLC. In some cases, the resulting carbinamine (9) was treated with HCl (1.0 Min Et2O) to afford the corresponding hydrochloride salt. The salt was then isolated by filtration.
(i) (4-methoxyphenyl)(phenyl)methanamine (9a)
Figure US08350047-20130108-C00033
9a isolated as a clear, pale yellow oil: 1H NMR [300 MHz, (CD3)2SO]δ 7.40-7.10 (7H, m), 6.85 (2H, dd, J=7.0, 2.0 Hz), 5.02 (1H, s), 3.70 (3H, s), 2.08 (2H, br s); optical rotation αD 21=10.9° (c=1.00, MeOH)
(ii) (4-methoxyphenyl)(p-tolyl)methanaminium chloride (9b)
Figure US08350047-20130108-C00034
9b was isolated as a white solid: m.p. (Et2O)=257-260° C.; 1H NMR (300 MHz, CD3OD) δ 7.50-7.39 (5H, m), 7.33-7.22 (4H, m), 5.60 (1H, s), 4.98 (3H, br s), 2.33 (3H, s); 13C NMR (75 MHz, CD3OD) δ 140.23, 138.71, 135.62, 130.83, 130.27, 129.95, 128.33, 59.18, 21.11; optical rotation αD 21=65.7° (c=1.00, MeOH)
(iii) (4-fluorophenyl)(4-methoxyphenyl)methanamine (9c)
Figure US08350047-20130108-C00035
(iv) (4-methoxyphenyl)(phenyl)methanamine (9d)
Figure US08350047-20130108-C00036
(v) phenyl(p-tolyl)methanamine (9e)
Figure US08350047-20130108-C00037
(vi) (4-fluorophenyl)(phenyl)methanaminium chloride (9f)
Figure US08350047-20130108-C00038
9f isolated as a white solid: 1H NMR (400 MHz, CD3OD) δ 7.50-7.42 (7H, m), 7.25-7.15 (2H, m), 5.72 (1H, s), 4.94 (3H, br s).
Discussion
The addition of aryl boronic acids to aldehydes in the presence of a rhodium catalyst and DUPHOS, when first pretreated with ammonia, has been found to lead cleanly and enantioselectively to the formation of the corresponding secondary carbinamines under mild reaction conditions as seen in Table 4. The resulting secondary carbinamines were easily isolated and uniformly obtained in good yields.
TABLE 1
Reaction of aldehydes with allylboronic acid in the presence of ammonia
Figure US08350047-20130108-C00039
entry R yield (%)
3a PhCH2OCH2 93
3b 4-CH3OC6H4 91
3c n-C7H15 90
3d t-Bu 82
3e PhCH2CH2 95
3f Cyclohexyl 87
3g 3-CH3OC6H4 84
3h 4-NCC6H4 86
3i 2-Pyridyl 70
3j 3-Indolyl 72
TABLE 2
Reaction of aldehydes with (E)- or (Z)-crotylboronic
acids in the presence of ammonia
Figure US08350047-20130108-C00040
entry R reagent d. r. yield (%)
5a PhCH2OCH2 4a 95:5 81
5b 4-CH3OC6H4 4a 96:4 89
5c 4-CH3OC6H4 4b 96:4 91
5d 3-Indolyl 4b 95:5 79
TABLE 3
Rhodium catalyzed addition of aryl boronic acids to aldehydes in the presence of ammonia
Figure US08350047-20130108-C00041
entry R1 R2 yield (%)
8a 4-BrC6H4 Ph 56
8b Ph 4-F3CC6H4 70
8c 4-CH3C6H4 2-Naphthyl 66
8d Ph 4-ClC6H4 79
TABLE 4
Rhodium catalyzed enantioselective addition of arylboronic acids to aldehydes in the presence of ammonia
Figure US08350047-20130108-C00042
entry R1 R2 yield (%) ee (%)
9a 4-MeOC6H4 Ph 65 39
9b 4-MeOC6H4 4-CH3C6H4 68 43
9c 4-MeOC6H4 4-FC6H4 70 48
9d Ph 4-MeOC6H4 61 45
9e Ph 4-MeC6H4 64 49
9f Ph 4-FC6H4 74 52

Claims (29)

1. A method of preparing a secondary amine of the formula Ia and/or Ib:
Figure US08350047-20130108-C00043
wherein
R1 is selected from C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, all of which are optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alknyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R2 to R6 are independently selected from H, C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl, C3-20cycloalkoxy, aryl, aryloxy, heteroaryl and heteroaryloxy, the latter 9 groups being optionally substituted and one or more of the carbons in C1-20alkyl, C1-20alkoxy, C2-20alkenyl, C2-20alkynyl, C3-20cycloalkyl or C3-20cycloalkoxy is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8;
R7 and R8 are independently selected from H, C1-20alkyl, C3-20cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted;
comprising reacting a compound of formula II:
Figure US08350047-20130108-C00044
wherein R1 is as defined for the compounds of formula Ia and Ib, with a compound of formula III:
Figure US08350047-20130108-C00045
wherein R2-R6 are as defined for the compounds of formulae Ia and Ib, in the presence of ammonia NH3 or an ammonia equivalent of the formula NH4 +X, wherein X is an anionic counterion, and optionally isolating the amine of the formula Ia and/or Ib.
2. The method according to claim 1, wherein R1 is selected from C1-10alkyl, C3-8cycloalkyl, aryl, and heteroaryl, all of which are optionally substituted and one or more of the carbons in C1-10alkyl or C3-8cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8, in which R7 and R8 are independently selected from H and C1-6alkyl.
3. The method according to claim 2, wherein one or more of the carbons in C1-10alkyl or C3-8cycloalkyl is optionally replaced with a heteroatom selected from O and S.
4. The method according to claim 1, wherein the optional substituents on R1 in the compounds of the formulae Ia, Ib and II are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted C1-6alkyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C2-6alkenyl, C2-6alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
5. The method according to claim 4, wherein the optional substituents on R1 in the compounds of the formulae Ia, Ib and II are independently selected from one to three of OH, F, Cl, Br, CN, NO2, CF3, OCF3, C1-4alkyl, C1-4alkoxy, phenyl, benzyl, benzyloxy and C(O)OC1-4alkyl.
6. The method according to claim 5, wherein the optional substituents on R1 in the compounds of the formulae Ia, Ib and II are independently selected from one to three of F, Cl, Br, C1-4alkoxy and benzyloxy.
7. The method according to claim 1, wherein R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H, C1-10alkyl, C3-12cycloalkyl, aryl and heteroaryl, the latter 4 groups being optionally substituted and one or more of the carbons in C1-10alkyl or C3-10cycloalkyl is optionally replaced with a heteromoiety selected from O, S, N, NR7 and NR7R8, in which R7 and R8 are independently selected from H and C1-6alkyl.
8. The method according to claim 7, wherein R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H and C1-6alkyl.
9. The method according to claim 8, wherein R2 to R6 in the compounds of the formulae Ia, Ib and III are independently selected from H and methyl.
10. The method according to claim 1, wherein the optional substituents on R2 and R6 in the compounds of the formulae Ia, Ib and III are independently selected from one or more of OH, halo, CN, NO2, C1-6alkyl, halo-substituted C1-6alkyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C2-6alkenyl, C2-6alkenyloxy, aryl, aryloxy, aryl(C1-4alkoxy), heteroaryl, heteroaryloxy, heteroaryl(C1-4alkoxy), NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
11. The method according to claim 1, wherein the method is performed in the presence of ammonia.
12. The method according to claim 1, wherein the method is performed in the presence of an ammonia equivalent of the formula NH4 +X, in which X is selected from halo, R9COO, R9SO4 and BF4 and in which R9 is selected from C1-10alkyl, C3-20cycloalkyl, aryl and heteroaryl, all of which are optionally substituted.
13. The method according to claim 12, wherein X is Cl or Br.
14. The method according to claim 13, wherein the optional substituents on R9 are independently selected from one or more of OH, halo, CN, NO2, phenyl, benzyl, C1-6alkoxy, halo-substituted C1-6alkoxy, C1-6alkyl, halo-substituted alkyl, C2-6alkenyl, C2-6alkenyloxy, NH2, NH(C1-6alkyl), N(C1-6alkyl)(C1-6alkyl), C(O)C1-6alkyl, C(O)OC1-6alkyl, SO2C1-6alkyl, SO2NH2, SO2NHC1-6alkyl and SC1-4alkyl.
15. The method according to claim 1, wherein the method is performed in a solvent.
16. The method according to claim 15, wherein the solvent is selected from methanol, ethanol, propanol, butanol, toluene, tetrahydrofuran, acetonitrile, benzene, dioxane, methylene chloride, liquid ammonia, ionic liquids and mixtures thereof.
17. The method according to claim 16, wherein the solvent is methanol.
18. The method according to claim 1, wherein the method is performed at a temperature of from −40° C. to +100° C.
19. The method according to claim 18, wherein the method is performed at room temperature.
20. The method according to claim 1, wherein the method is performed in the presence of a catalyst.
21. The method according to claim 20, wherein the catalyst is a transition metal catalyst.
22. The method according to claim 21, wherein the metal is selected from rhodium, ruthenium, iridium, copper, platinum, palladium and nickel.
23. The method according to claim 22, wherein the metal is rhodium.
24. The method according to claim 20, wherein the catalyst comprises a chiral or achiral ligand.
25. The method according to claim 24, wherein the chiral ligand is a phosphine, diphosphine, aminophosphine, amine, carbene or oxazoline.
26. The method according to claim 24, wherein in the compounds of formula III, R2 and R3 are different and enantiomerically enriched compounds of formulae Ia and/or Ib are prepared.
27. The method according to claim 1, wherein when R2 and R3 are different in compounds of the formulae Ia and/or Ib, the method further comprises chirally resolving the compounds of formulae Ia and/or Ib.
28. The method according to claim 27, wherein the chiral resolution comprises diastereomeric ester formation or diastereomeric salt formation.
29. The method according to claim 28, wherein the method further comprises separating the diastereomers using crystallization or chromatography.
US12/593,815 2007-03-30 2008-03-28 Methods of preparing secondary carbinamine compounds with boronic acids Expired - Fee Related US8350047B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/593,815 US8350047B2 (en) 2007-03-30 2008-03-28 Methods of preparing secondary carbinamine compounds with boronic acids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90900007P 2007-03-30 2007-03-30
PCT/CA2008/000567 WO2008119161A1 (en) 2007-03-30 2008-03-28 Methods of preparing secondary carbinamine compounds with boronic acids
US12/593,815 US8350047B2 (en) 2007-03-30 2008-03-28 Methods of preparing secondary carbinamine compounds with boronic acids

Publications (2)

Publication Number Publication Date
US20100298572A1 US20100298572A1 (en) 2010-11-25
US8350047B2 true US8350047B2 (en) 2013-01-08

Family

ID=39807745

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/593,815 Expired - Fee Related US8350047B2 (en) 2007-03-30 2008-03-28 Methods of preparing secondary carbinamine compounds with boronic acids

Country Status (3)

Country Link
US (1) US8350047B2 (en)
CA (1) CA2682363A1 (en)
WO (1) WO2008119161A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2249203A1 (en) 1997-10-07 1999-04-07 Ethicon Endo-Surgery, Inc. A tissue stabilization device for use during surgery having spherical curved feet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0923544B1 (en) * 1996-06-28 2008-10-15 University of Southern California Method for the synthesis of amines and amino acids with organoboron derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2249203A1 (en) 1997-10-07 1999-04-07 Ethicon Endo-Surgery, Inc. A tissue stabilization device for use during surgery having spherical curved feet

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Dhudshia, B., Tiburcio, J. and Thadani, A.N. Chem. Commun. 2005, 5551-5553.
H. C. Brown, U. S. Racherla and P. J. Pellechia, J. Org. Chem., 1990, 55, 1868.
M. Sugiura, K. Hirano and S. Kobayashi, J. Am. Chem. Soc., 2004, 126, 7182-7183.
S. Kobayashi, K. Hirano and M. Sugiura, J. Chem. Commun., 2005, 104-105.
Yamamoto, Y. and Asao, N., Chem. Rev., 1993, 93, 2207.

Also Published As

Publication number Publication date
US20100298572A1 (en) 2010-11-25
WO2008119161A1 (en) 2008-10-09
CA2682363A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
Busscher et al. Efficient preparation of an N-aryl β-amino acid via asymmetric hydrogenation and direct asymmetric reductive amination en route to Ezetimibe
WO2018060512A1 (en) Process for preparing chiral amines
Rubio-Pérez et al. One-pot stibine modified Co2 (CO) 8 catalyzed reductive N-alkylation of primary amides with carbonyl compounds
JP2021509684A (en) Manganese-catalyzed hydrogenation of esters
Ruan et al. Catalytic Asymmetric Alkynylation and Arylation of Aldehydes by an H8‐Binaphthyl‐Based Amino Alcohol Ligand
Denmark et al. Organocerium additions to proline-derived hydrazones: synthesis of enantiomerically enriched amines
US6369243B1 (en) Chemical transformation of substrates using nonmetallic, organic catalyst compositions
Luo et al. Catalytic asymmetric (4+ 1) annulation of nitroalkenes with allylic acetates: stereoselective synthesis of isoxazoline N-oxides
Gök et al. Novel C2-symmetric bisoxazolines with a chiral trans-(2R, 3R)-diphenylcyclopropane backbone: preparation and application in several enantioselective catalytic reactions
US8350047B2 (en) Methods of preparing secondary carbinamine compounds with boronic acids
US6515137B2 (en) Catalytic processes employing chiral imidazolidinone-based catalyst composition
Sengoku et al. Zinc Hydroxide‐Catalyzed Asymmetric Allylation of Acetophenones with Amido‐Functionalized Allylboronate in Water
US20170361310A1 (en) Composition of matter
US8383859B2 (en) Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia
Xu et al. Enantioselective addition of diethylzinc to aldehydes catalyzed by optically active C2‐symmetrical bis‐β‐amino alcohols
Hegedus et al. Synthesis of (S)-(+)-2-(N-benzylamino) butan-1-ol from its Schiff Base by Catalytic Hydrogenation over Palladium
US8143451B2 (en) Methods of preparing tertiary carbinamine compounds
CZ84996A3 (en) Process for preparing intermediates for preparing spiro-substituted derivatives of glutaramide
US10196338B2 (en) Chiral diamine compounds for the preparation of chiral alcohols and chiral amines
US9340519B2 (en) Paracyclophane-based ligands, their preparation and use in catalysis
Sulzer-Mosse et al. Synthesis and Use of 3, 3′-Bimorpholine Derivatives in Asymmetric Michael Addition and Intramolecular Aldol Reaction
Zhang et al. Efficient.
US20080227978A1 (en) Method for the Preparation of Enantiomerically Enriched Secondary Alcohols by the Addition of Organoaluminium Reagents to Carbonyl Compounds
JP2013112673A (en) HETEROARENESULFONYL CINCHONA ALKALOID AMINE CATALYST AND MANUFACTURING METHOD FOR β-AMINOCARBONYL COMPOUND USING THE SAME
Dalmolen Synthesis and application of new chiral amines in Dutch resolution: Family Behaviour in Nucleation Inhibition.

Legal Events

Date Code Title Description
REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20170108